Literature DB >> 16568946

The role of histone modifications in epigenetic transitions during normal and perturbed development.

S Kubicek1, G Schotta, M Lachner, R Sengupta, A Kohlmaier, L Perez-Burgos, Y Linderson, J H A Martens, R J O'Sullivan, B D Fodor, M Yonezawa, A H F M Peters, T Jenuwein.   

Abstract

Epigenetic mechanisms control eukaryotic development beyond DNA-stored information. DNA methylation, histone modifications and variants, nucleosome remodeling and noncoding RNAs all contribute to the dynamic make-up of chromatin under distinct developmental options. In particular, the great diversity of covalent histone tail modifications has been proposed to be ideally suited for imparting epigenetic information. While most of the histone tail modifications represent transient marks at transcriptionally permissive chromatin, some modifications appear more robust at silent chromatin regions, where they index repressive epigenetic states with functions also outside transcriptional regulation. Under-representation of repressive histone marks could be indicative of epigenetic plasticity in stem, young and tumor cells, while committed and senescent (old) cells often display increased levels of these more stable modifications. Here, we discuss profiles of normal and aberrant histone lysine methylation patterns, as they occur during the transition of an embryonic to a differentiated cell or in controlled self-renewal vs pro-neoplastic or metastatic conditions. Elucidating these histone modification patterns promises to have important implications for novel advances in stem cell research, nuclear reprogramming and cancer, and may offer novel targets for the combat of tumor cells, potentially leading to new diagnostic and therapeutic avenues in human biology and disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16568946     DOI: 10.1007/3-540-37633-x_1

Source DB:  PubMed          Journal:  Ernst Schering Res Found Workshop        ISSN: 0947-6075


  13 in total

1.  Pathology tissue-chromatin immunoprecipitation, coupled with high-throughput sequencing, allows the epigenetic profiling of patient samples.

Authors:  Mirco Fanelli; Stefano Amatori; Iros Barozzi; Matias Soncini; Roberto Dal Zuffo; Gabriele Bucci; Maria Capra; Micaela Quarto; Gaetano Ivan Dellino; Ciro Mercurio; Myriam Alcalay; Giuseppe Viale; Pier Giuseppe Pelicci; Saverio Minucci
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-24       Impact factor: 11.205

Review 2.  Epigenetic programming of mesenchymal stem cells from human adipose tissue.

Authors:  Andrew C Boquest; Agate Noer; Philippe Collas
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

3.  The trithorax group protein Ash2l is essential for pluripotency and maintaining open chromatin in embryonic stem cells.

Authors:  Ma Wan; Jiancong Liang; Yuanyan Xiong; Fengtao Shi; Yi Zhang; Weisi Lu; Quanyuan He; Dong Yang; Rui Chen; Dan Liu; Michelle Barton; Zhou Songyang
Journal:  J Biol Chem       Date:  2012-12-13       Impact factor: 5.157

4.  Virion-mediated transfer of SV40 epigenetic information.

Authors:  Barry Milavetz; Les Kallestad; Amanda Gefroh; Nicholas Adams; Emily Woods; Lata Balakrishnan
Journal:  Epigenetics       Date:  2012-06-01       Impact factor: 4.528

5.  Pregnancy-induced chromatin remodeling in the breast of postmenopausal women.

Authors:  Jose Russo; Julia Santucci-Pereira; Ricardo López de Cicco; Fathima Sheriff; Patricia A Russo; Suraj Peri; Michael Slifker; Eric Ross; Maria Luiza S Mello; Benedicto C Vidal; Ilana Belitskaya-Lévy; Alan Arslan; Anne Zeleniuch-Jacquotte; Pal Bordas; Per Lenner; Janet Ahman; Yelena Afanasyeva; Goran Hallmans; Paolo Toniolo; Irma H Russo
Journal:  Int J Cancer       Date:  2012-01-03       Impact factor: 7.396

6.  Lidocaine sensitizes the cytotoxicity of cisplatin in breast cancer cells via up-regulation of RARβ2 and RASSF1A demethylation.

Authors:  Kehan Li; Jianxue Yang; Xuechang Han
Journal:  Int J Mol Sci       Date:  2014-12-17       Impact factor: 5.923

Review 7.  Molecular pathways involved in pregnancy-induced prevention against breast cancer.

Authors:  Maria Barton; Julia Santucci-Pereira; Jose Russo
Journal:  Front Endocrinol (Lausanne)       Date:  2014-12-10       Impact factor: 5.555

8.  Epidermal stem cells are defined by global histone modifications that are altered by Myc-induced differentiation.

Authors:  Michaela Frye; Amanda G Fisher; Fiona M Watt
Journal:  PLoS One       Date:  2007-08-22       Impact factor: 3.240

9.  Development of pan-specific antibody against trimethyllysine for protein research.

Authors:  Ziqian Liang; Ronald Pc Wong; Lin Hong Li; Hesheng Jiang; Hao Xiao; Gang Li
Journal:  Proteome Sci       Date:  2008-01-22       Impact factor: 2.480

10.  The genomic signature of breast cancer prevention.

Authors:  Jose Russo; Julia Santucci-Pereira; Irma H Russo
Journal:  Genes (Basel)       Date:  2014-02-26       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.